Indian startup develops AI-based blood test to detect 32 cancers early

Even as detecting cancer early remains key, a Gurugram-based startup PredOmix has developed a novel blood test that can detect about 32 cancers in both men and women, with 98 per cent accuracy. The company's OncoVeryx-F is a patented technology that combines metabolomics (study of small molecules) and Artificial Intelligence (AI) to identify metabolite signatures of multiple cancers in a single test. "Metabolomics is a particularly suitable technique for cancer detection since metabolic reprogramming constitutes one of the hallmarks of cancer cells. By using appropriate big data algorithms, metabolite asignatures' characteristic of cancer can be accurately extracted from the serum metabolome," Dr. Kanury V.S. Rao, Co-Founder & Chief Scientific Officer (CSO), PredOmix, told IANS. The test was first launched in 2022 and identified four major female-specific malignancies in a single blood test: breast, endometrium, cervix, and ovary.